CXCR2 and neoplasm: To determine if chemokine receptor CXCR2 is involved in RT-induced neutrophilic infiltration into the tumor, we blocked the ability of CXCR2 to bind to its corresponding ligands by treating mice with CXCR2 antagonist AZD5069 (Figure 1A) [23].